No Data
No Data
Piper Sandler Maintains Savara(SVRA.US) With Buy Rating, Maintains Target Price $16
H.C. Wainwright Maintains Savara(SVRA.US) With Buy Rating, Maintains Target Price $10
Savara Management to Meet Virtually With Piper Sandler
Evercore Maintains Savara(SVRA.US) With Buy Rating, Maintains Target Price $7
Evercore ISI Remains a Buy on Savara (SVRA)
Savara Announces Patient Journey Map for People Living With Autoimmune Pulmonary Alveolar Proteinosis (APAP) Accepted for Poster Presentation at the CHEST 2024 Annual Meeting
No Data
No Data